Business Wire

QD Vision Corrects Factually Incorrect Statements Made by Nanoco Group, LLC

6.10.2015 06:00 | Business Wire

Del

QD Vision, the leader in quantum dot technology for QLED displays, responds to manifestly incorrect and misleading statements issued yesterday by Nanoco Group PLC.

In addition to mischaracterizing the relative competitiveness, energy efficiency, and environment friendliness of the QD Vision dots as compared to any actual or potential competitor, in its statement, Nanoco also wrongly claims:

"There is no legal basis for keeping or allowing new cadmium displays in the market, and that “and the previous cadmium quantum dot exemption expired with the Parliament's vote.

This is incorrect. Taken directly from the Parliament’s May 21, 2015 press release, the Parliament’s request “does not ban cadmium quantum dots, but will trigger a new assessment. There are therefore no market distortions, as the current exemption remains valid until revoked.”

Exemption 39(b) from the RoHS Directive (Restriction of Hazardous Substances Directive) remains valid and enforceable as per the European Commission’s statement, providing a legal basis for the shipping of these displays.

Nanoco claims that alternatives to cadmium based quantum dots “are readily available…”

This is incorrect. There is no alternative material on the market with the same color gamut and energy efficiency. In addition, there are no monitors on the market based on indium phosphide.

Nanoco also claimed:

“Rather than accepting the European Parliament's vote effectively ending the exemption, the European Commission decided to reassess whether the exemption should be kept in place for the future.”

This is incorrect. The MEPs called for a reassessment based on the belief that new information was available regarding market alternatives. The European Commission never changed its view that the exemption should be extended. The Commission is now following the MEP’s request for a reassessment. As noted, the exemption remains in force and effect.

Quote from QD Vision:

"We look forward to a swift technical assessment of the alternatives in this exciting segment – one that will plainly demonstrate that safe and energy-efficient cadmium selenide quantum dots are the only competitive solution for Europe," said Mustafa Ozgen, CEO of QD Vision. "I don’t think any potential competitor intentionally attempted to mislead the European Parliament by their filings, but they seem to be unfamiliar with the significant advantages of the cadmium selenide-based quantum dots product in color, energy efficiency and environmental friendliness and the inability of alternative products to match these important performance characteristics.”

About QD Vision, Inc.

QD Vision, Inc. is a leader in quantum dot display technology for QLED displays. Quantum dot technology is a superior next-generation alternative to OLED displays, providing unparalleled color representation at a highly competitive LCD cost structure. Color IQ quantum dot technology from QD Vision provides a unique optical component solution capable of delivering “full-gamut” color to the display industry. Founded in 2004, the company has raised more than $100 million in financing from top-tier venture capital firms and is headquartered in Lexington, Massachusetts. http://www.coloriq.com

COLOR IQ, QLED, and QD VISION are trademarks of QD Vision, Inc. The COLOR IQ and QD VISION trademarks are registered in one or more countries.

Contact information

QD Vision
Michele Dempsey, 781-652-7525
mdempsey@qdvision.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Altierre Strengthens Executive Team in Europe With Hiring of Guillaume Vicot and Niclas Qvist22.8.2017 12:00Pressemelding

Altierre Corp., a provider of the world’s highest density, ultra-low energy, long-range wireless technology and applications for the Internet of Things (IoT) market, today announced two additions to its France-based European executive team. Guillaume Vicot has joined the company as General manager, Europe, Middle East and Asia (EMEA) and Niclas Qvist has joined as Vice President, Partner management & Marketing. Vicot joins Altierre’s management team after 17 successful years in the Auto-ID industry, barcode scanning and mobile computing. He most recently served as Vice President of sales, Western Europe, for PSC / Datalogic, leader in the bar code scanning industry, where he oversaw a team of more than 100 people and developed a tactical go-to-market strategy, achieving revenue well over US$100 million. “Guillaume has many top level strategic relationships with retailers

IFF to Present at the Barclays Global Consumer Staples Conference21.8.2017 20:15Pressemelding

Regulatory News: International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF), a leading innovator of sensory experiences that move the world, today announced that Andreas Fibig, Chairman and Chief Executive Officer will present at the Barclays Global Consumer Staples Conference in Boston, MA on Thursday, September 7, 2017 at 11:15 a.m. EDT. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Meet IFF International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF) is a leading innovator of sensorial experiences that move the world. At the heart of our company, we are fueled by a sense of discovery, constantly asking “what if?”. That passion for explorati

Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform21.8.2017 20:11Pressemelding

Celularity, Inc., a newly formed biotechnology company, today announced its acceleration of cell and tissue regenerative therapies to address unmet medical needs in cancer and chronic and degenerative disease. Celularity completed their Series A financing with contributions from several biopharma companies, including Sorrento Therapeutics, United Therapeutics Corporation and Human Longevity, Inc., and entrepreneurial investors. Celularity has been created through the contributions of extensive intellectual property, clinical-stage assets, basic and clinical research, and development expertise including: Several clinical-stage immuno-oncology and regenerative medicine assets and a pipeline of pre-clinical assets Proprietary allogeneic (“readily accessible”) immunotherapy platform 200+ issued and pending patents in cell therapy

European Commission Grants New Indication for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG)21.8.2017 13:25Pressemelding

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the European Commission (EC) approved the extension of the indication for Soliris® (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody-positive. Soliris is the first and only complement-based therapy approved in the European Union (EU) for this ultra-rare subset of patients.1-4 Patients with refractory gMG can have difficulties walking, talking, swallowing and breathing normally despite therapies currently used for MG. Exacerbations and crises of their disease may require hospitalization and intensive care and may be life-threatening.5-7 Soliris will be launched for this new indication initially in Germany, and Alexion is evaluating launches in additional EU countries. “Patients with refractory gMG have exhausted multiple the

IntegenX Applauds the Passage of the Rapid DNA Act of 201721.8.2017 12:00Pressemelding

IntegenX Inc., the global market leader for Rapid DNA human identification, applauds the signing into law of S.139 and HR.510, The Rapid DNA Act of 2017. The legislation will allow law enforcement agencies, under standards and guidelines established by the FBI, to perform real-time DNA testing at time of arrest, within booking stations. Similar to how fingerprint analysis has evolved from a paper and ink practice to a point-of-action technology, DNA testing has now become possible in 90 minutes within a booking station, while a suspect is still in custody. With processing times reduced from weeks to less than two hours, the potential to identify or exonerate a suspect quickly will make a meaningful impact on law enforcement. IntegenX thanks U.S. Senate sponsor Senator Orrin Hatch (R-UT) and lead co-sponsor Senator Dianne Feinstein (D-CA) as well as House sponsor Congressman

PPG Completes COLORFUL COMMUNITIES Project at Primary School in Kecskemét, Hungary21.8.2017 08:03Pressemelding

PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Kecskemét, Hungary, that helped revitalize the learning environment of the Corvin Mátyás primary school. The Colorful Communities program provides PPG volunteers and products along with financial contributions to bring color and vitality to communities where the company operates around the world, such as in Kecskemét, where the PPG automotive service team operates with 33 employees. The project brought together more than 140 PPG and community volunteers who spent three days at the school revitalizing four classrooms, four changing rooms and the playground. PPG provided more than $20,000 to assist with the project, including more than 460 liters of Héra ® Prémium waterborne interior paint and Trinát ® Aqua wate

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom